65,437 trials
Down Syndrome · Intellectual Disability
Primary: Efficacy of the Drug Memantine as Assessed by Change in Score on the California Verbal Learning Test-II (CVLT-II) Short Form Total Free Recall — 3.3; 3.49 score on a…
Duchenne Muscular Dystrophy
Primary: Percent Change From Baseline in Dystrophin Level at Week 40, as Measured by ECL — 6.559 percent change
Clear Cell Renal Cell Carcinoma · Recurrent Renal Cell Cancer · Stage IV Renal Cell Cancer
Primary: Confirmed Response Rate (Complete Response and Partial Response) as Assessed by RECIST 1.1 Criteria — 14; 7; 4 Participants
Heart Failure
Primary: CRT Response — 116; 105 Participants — p=0.17
Recurrent Lung Squamous Cell Carcinoma · Stage IV Lung Squamous Cell Carcinoma AJCC v7
Primary: Objective Response Rate (Complete Response [CR] + Partial Response [PR]) — 3; 1; 0; 9 Participants
Type 2 Diabetes Mellitus
Primary: Percentage of Participants With Serious Adverse Events (SAEs) — 1.18 percentage of participants
Men With Mild Abdominal Obesity
Primary: Amino Acid Profile (Blood Biomarkers) — 31.1; 31.1; 30 mmol/L
Hypothyroidism;Postablative
Primary: Thyroid Stimulating Hormone (TSH) — -0.676 mIU/L — p=<0.0001
Follicular Lymphoma (FL/Indolent NHL) · Aggressive NHL (a NHL) · Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
Primary: Phase 1: Number of Participants With a Dose Limiting Toxicity (DLT) — 0; 0; 0; 0 Participants
Pancreatic Neuroendocrine Tumor G1 · Pancreatic Neuroendocrine Tumor G2 · Refractory Pancreatic Neuroendocrine Carcinoma
Primary: Overall Response Rate — 0 proportion of participants
Polyp of Colon · Endoscopic Mucosal Resection · Recurrent Colon Adenoma
Primary: Primary Effectiveness Endpoint Defined as the Ability of the EndoRotor to Resect Lesions Without Concomitant Use of Other Resection Modalities and With no Device-related…
Depression
Primary: Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Pre mPATH Use — 224; 94; 55; 165 Participants
Pain · Breastfeeding
Primary: Breastfeeding at 6 Weeks Post Delivery — 100; 99; 102; 3 Participants — p=.34
Arthritis, Rheumatoid
Primary: Percentage of Participants With American College of Rheumatology 20% (ACR20) Response at Week 12 — 33.96; 36.17 Percentage of participants — p=0.591
Communicable Diseases · Infection · Anti-Infective Agents
Primary: Number of Participants With Acquisition of Any New Antibiotic-resistant Organism — 9; 12 Participants